Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.655 USD | -3.55% | +12.09% | -1.77% |
May. 13 | Recursion Pharmaceuticals Says BioHive-2 AI Supercomputer Completed | MT |
May. 10 | Recursion Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.77% | 2.38B | |
+7.25% | 113B | |
+11.00% | 106B | |
+1.02% | 22.27B | |
-12.23% | 22.22B | |
-5.71% | 19.43B | |
-37.85% | 17.87B | |
-5.97% | 17.24B | |
+7.39% | 14.29B | |
+34.90% | 12.52B |
- Stock Market
- Equities
- RXRX Stock
- News Recursion Pharmaceuticals, Inc.
- Recursion Pharmaceuticals Insider Sold Shares Worth $348,075, According to a Recent SEC Filing